Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence

Informazioni relative al progetto

BIOSIM

ID dell’accordo di sovvenzione: 778586

DOI 10.3030/778586

Progetto chiuso

Data della firma CE 19 Settembre 2017

Data di avvio 1 Ottobre 2017

Data di completamento 31 Maggio 2019

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale € 2 029 325,00

Contributo UE € 2 029 325,00

Coordinato da

VALITACELL LTD
Ireland

Risultati finali

Demonstrators, pilots, prototypes (3)

CE marked product

Ensuring that Valitacell product and associated has the required CE registration

Peer reviewed publication submitted

Submission of results and outline of applicability and benefits of technology in a report to be published in a peer reviewed journal or online publication

Results exchanged

Review of the results from the four sites and analysis of same in order to determine the final model to be adopted in the product

Pubblicazioni

Peer reviewed articles (1)

High-throughput quantitation of Fc-containing recombinant proteins in cell culture supernatant by fluorescence polarization spectroscopy

Autori: Ben Thompson, Jerry Clifford, Mike Jenns, Andrew Smith, Ray Field, Kalpana Nayyar, David C. James
Pubblicato in: Analytical Biochemistry, Numero 534, 2017, Pagina/e 49-55, ISSN 0003-2697
Editore: Academic Press
DOI: 10.1016/j.ab.2017.07.013

Diritti di proprietà intellettuale

Patent (2)

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Numero candidatura/pubblicazione: EP 15736411
Data: 2015-06-18
Candidato/i: VALITACELL LTD

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Numero candidatura/pubblicazione: EP 15718799
Data: 2015-04-02
Candidato/i: VALITACELL LTD

Trademark (1)

chemstress

Numero candidatura/pubblicazione: TM 017262511
Data: 2018-02-12
Candidato/i: VALITACELL LTD

Other (1)

A METHOD OF PREDICTING RELATIVE FED BATCH PRODUCTION TITER OF A PANEL OF CLONALLY-DERIVED PRODUCER CELLS

Numero candidatura/pubblicazione: EP 14830805
Data: 2014-12-17
Candidato/i: VALITACELL LTD